A detailed history of Banco Santander, S.A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Banco Santander, S.A. holds 339,828 shares of GILD stock, worth $29.9 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
339,828
Previous 216,072 57.28%
Holding current value
$29.9 Million
Previous $15.8 Million 47.31%
% of portfolio
0.29%
Previous 0.19%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$63.15 - $72.88 $7.82 Million - $9.02 Million
123,756 Added 57.28%
339,828 $23.3 Million
Q1 2024

May 10, 2024

BUY
$71.58 - $87.29 $15.5 Million - $18.9 Million
216,072 New
216,072 $15.8 Million
Q1 2023

May 10, 2023

BUY
$77.31 - $88.08 $190,414 - $216,941
2,463 New
2,463 $204,000
Q2 2022

Jul 28, 2022

SELL
$57.72 - $65.01 $1.22 Million - $1.38 Million
-21,213 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$57.92 - $72.58 $328,116 - $411,165
5,665 Added 36.44%
21,213 $1.26 Million
Q4 2021

Feb 09, 2022

BUY
$64.88 - $73.64 $79,672 - $90,429
1,228 Added 8.58%
15,548 $1.13 Million
Q3 2021

Nov 08, 2021

SELL
$67.69 - $73.03 $91,246 - $98,444
-1,348 Reduced 8.6%
14,320 $1 Million
Q2 2021

Jul 29, 2021

BUY
$63.47 - $69.35 $994,447 - $1.09 Million
15,668 New
15,668 $1.08 Million
Q4 2020

Feb 12, 2021

SELL
$56.65 - $64.55 $526,731 - $600,185
-9,298 Closed
0 $0
Q3 2020

Nov 09, 2020

SELL
$62.1 - $78.08 $405,326 - $509,628
-6,527 Reduced 41.24%
9,298 $588,000
Q2 2020

Aug 05, 2020

SELL
$72.34 - $84.0 $88.9 Million - $103 Million
-1,228,415 Reduced 98.73%
15,825 $1.22 Million
Q1 2020

May 11, 2020

BUY
$62.63 - $80.22 $77 Million - $98.6 Million
1,228,709 Added 7911.33%
1,244,240 $93 Million
Q4 2019

Feb 07, 2020

SELL
$61.62 - $67.78 $105,123 - $115,632
-1,706 Reduced 9.9%
15,531 $1.01 Million
Q3 2019

Nov 06, 2019

SELL
$62.51 - $69.0 $57.2 Million - $63.1 Million
-914,982 Reduced 98.15%
17,237 $1.09 Million
Q2 2019

Aug 07, 2019

BUY
$61.87 - $69.38 $56.5 Million - $63.4 Million
913,442 Added 4864.69%
932,219 $63 Million
Q1 2019

May 13, 2019

BUY
$62.53 - $70.05 $554,766 - $621,483
8,872 Added 89.57%
18,777 $1.22 Million
Q4 2018

Feb 12, 2019

BUY
$60.54 - $79.0 $95,955 - $125,215
1,585 Added 19.05%
9,905 $619,000
Q3 2018

Nov 13, 2018

SELL
$71.28 - $78.92 $514,142 - $569,249
-7,213 Reduced 46.44%
8,320 $643,000
Q2 2018

Aug 14, 2018

SELL
$64.88 - $75.68 $99,331 - $115,866
-1,531 Reduced 8.97%
15,533 $1.1 Million
Q1 2018

May 14, 2018

SELL
$72.84 - $88.8 $1.16 Million - $1.41 Million
-15,904 Reduced 48.24%
17,064 $1.29 Million
Q4 2017

Feb 14, 2018

SELL
$71.15 - $83.52 $201,923 - $237,029
-2,838 Reduced 7.93%
32,968 $2.36 Million
Q3 2017

Nov 13, 2017

SELL
$72.11 - $85.47 $29,997 - $35,555
-416 Reduced 1.15%
35,806 $2.9 Million
Q2 2017

Aug 11, 2017

BUY
N/A
36,222
36,222 $2.57 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Banco Santander, S.A. Portfolio

Follow Banco Santander, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.